Advertisement
Posttraumatic stress disorder symptoms are associated with an increased risk for ovarian cancer

PTSD Symptoms Tied to Higher Risk for Ovarian Cancer

0
Correlation moderately attenuated after adjustment for health and ovarian cancer risk factors
A new risk prediction calculator can make health risk predictions for several outcomes simultaneously in postmenopausal women

Risk Calculator Can Help Predict Postmenopausal Morbidity

0
The online tool assesses risks for heart disease, stroke, falls, cancer for postmenopausal women
Patients with multiple myeloma may receive a survival benefit from being treated at high-volume facilities

Care at High-Volume Facility May Cut Mortality in Multiple Myeloma

0
Mortality did not differ for those treated by NCICCC MM specialists, highest-volume community oncologists
The breast cancer death rate is continuing to decline

Breast Cancer Mortality Rate Continues to Decline in the U.S.

0
Pace of decline slowed from 1.9 percent during 1998 to 2011 to 1.3 percent during 2011 to 2017
The rate of head and neck cancers has risen since the 1970s

Incidence of HPV-Positive Head and Neck Cancer Up in the U.S.

0
From 2013 to 2014, incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons

September 2019 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2019. This roundup includes...
Compared with placebo

No Benefit Found for High-Dose Vitamin C Infusions in Sepsis, ARDS

0
No differences seen versus placebo in organ dysfunction scores, biomarkers of inflammation or vascular injury
More patients with advanced melanoma receiving nivolumab plus ipilimumab or nivolumab alone have sustained long-term survival at five years compared with those receiving ipilimumab alone

Nivolumab Therapy Prolongs Survival in Advanced Melanoma

0
Overall survival at five years longer with nivolumab + ipilimumab, nivolumab alone versus ipilimumab
Delay in referral for colorectal cancer in primary care is associated with low cancer suspicion

Low Cancer Suspicion Tied to Delay in CRC Referral in Primary Care

0
Presentation without alarm symptoms linked to long duration to referral in multivariable analysis
Real-world evidence shows that rivaroxaban reduces the risk for recurrent venous thromboembolism in morbidly obese patients

Rivaroxaban Cuts Recurrent Blood Clots in Obese Patients

0
Patients on rivaroxaban also have lower health care resource utilization than those on warfarin